These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11745720)
41. Preparation of cefpodoxime proxetil fine particles using supercritical fluids. Chu J; Li G; Row KH; Kim H; Lee YW Int J Pharm; 2009 Mar; 369(1-2):85-91. PubMed ID: 19041383 [TBL] [Abstract][Full Text] [Related]
42. Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation. Song M; Li N; Sun S; Tiedt LR; Liebenberg W; de Villiers MM Farmaco; 2005 Mar; 60(3):261-7. PubMed ID: 15784247 [TBL] [Abstract][Full Text] [Related]
43. Development of long-acting injectable suspensions by continuous antisolvent crystallization: An integrated bottom-up process. Nandi S; Padrela L; Tajber L; Collas A Int J Pharm; 2023 Dec; 648():123550. PubMed ID: 37890647 [TBL] [Abstract][Full Text] [Related]
44. Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters. Schubert MA; Müller-Goymann CC Eur J Pharm Biopharm; 2003 Jan; 55(1):125-31. PubMed ID: 12551713 [TBL] [Abstract][Full Text] [Related]
45. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process. Miyazaki Y; Onuki Y; Yakou S; Takayama K Int J Pharm; 2006 Nov; 324(2):144-51. PubMed ID: 16828994 [TBL] [Abstract][Full Text] [Related]
46. Micronization of silybin by the emulsion solvent diffusion method. Zhang ZB; Shen ZG; Wang JX; Zhang HX; Zhao H; Chen JF; Yun J Int J Pharm; 2009 Jul; 376(1-2):116-22. PubMed ID: 19409464 [TBL] [Abstract][Full Text] [Related]
47. Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol). Bromberg L; Rashba-Step J; Scott T Biophys J; 2005 Nov; 89(5):3424-33. PubMed ID: 16254391 [TBL] [Abstract][Full Text] [Related]
48. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498 [TBL] [Abstract][Full Text] [Related]
49. Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer. Hansen J; Kleinebudde P Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745799 [TBL] [Abstract][Full Text] [Related]
50. Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer. Maghsoodi M; Nokhodchi A Adv Pharm Bull; 2016 Dec; 6(4):607-616. PubMed ID: 28101468 [No Abstract] [Full Text] [Related]
51. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. Rosca ID; Watari F; Uo M J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636 [TBL] [Abstract][Full Text] [Related]
52. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs. Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922 [TBL] [Abstract][Full Text] [Related]
53. Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-β-cyclodextrin prepared using the liquid antisolvent precipitation and solvent removal combination methods. Wu W; Zu Y; Zhao X; Zhang X; Wang L; Li Y; Wang L; Zhang Y; Lian B Drug Dev Ind Pharm; 2017 Aug; 43(8):1366-1377. PubMed ID: 28402147 [TBL] [Abstract][Full Text] [Related]
54. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder. Lee HL; Vasoya JM; Cirqueira ML; Yeh KL; Lee T; Serajuddin AT Mol Pharm; 2017 Apr; 14(4):1278-1291. PubMed ID: 28245127 [TBL] [Abstract][Full Text] [Related]
55. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
56. Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt. Paluch KJ; Tajber L; Elcoate CJ; Corrigan OI; Lawrence SE; Healy AM J Pharm Sci; 2011 Aug; 100(8):3268-3283. PubMed ID: 21472730 [TBL] [Abstract][Full Text] [Related]
57. Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Trotta M; Cavalli R; Carlotti ME; Battaglia L; Debernardi F Int J Pharm; 2005 Jan; 288(2):281-8. PubMed ID: 15620868 [TBL] [Abstract][Full Text] [Related]
58. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan. Tran TT; Tran PH; Park JB; Lee BJ Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745 [TBL] [Abstract][Full Text] [Related]
59. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV; Olivier JC Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562 [TBL] [Abstract][Full Text] [Related]
60. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent. Zhang Y; Zhang Y; Guo S; Huang W Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]